THE OFFICIAL NEWS SOURCE OF ACR CONVERGENCE 2022 • NOVEMBER 10-14

#ACR22 SESSION COVERAGE



  • Experts review fundamentals of modeling categorical data at Stats Bootcamp II

    Experts review fundamentals of modeling categorical data at Stats Bootcamp II

    In the second of three sessions dedicated to better understanding how to use research statistics, Becki Cleveland, PhD, and Todd Schwartz, PhD, presented an overview of methods for modeling categorical variables rheumatologic researchers may encounter, which can greatly affect the impact and validity of one’s data. READ MORE

  • FDA gives update on pediatric drug shortages and approvals

    FDA gives update on pediatric drug shortages and approvals

    In 2022, the U.S. Food and Drug Administration approved the use of new agents for pediatric lupus nephritis, juvenile psoriatic arthritis, and enthesitis-related arthritis. Amit Golding, MD, PhD, highlighted the approvals of belimumab IV, ustekinumab, and secukinumab, and Cmdr. Hyun Son, PharmD, discussed the FDA’s role when drug shortages occur. READ MORE

  • Gluck lecturer outlines biomechanical model for OA etiology

    Gluck lecturer outlines biomechanical model for OA etiology

    In the Oscar S. Gluck, MD, Memorial Lecture, Joel Block, MD, described a biomechanistic and loading model of idiopathic osteoarthritis (OA). The conventional model presumes that all OA proceeds from similar processes. Therapeutic strategies involve controlling early inflammation and stabilizing joint structures. That these strategies have been uniformly unsuccessful suggests other factors are at work. READ MORE

POSTER SPOTLIGHT

Upcoming Industry Events

Upcoming Events